Por favor, use este identificador para citar o enlazar este ítem:
http://repositoriodspace.unipamplona.edu.co/jspui/handle/20.500.12744/1095
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Cordero Sanchez, Daniela. | - |
dc.contributor.author | Moreno Hernandez, Everth Andrés. | - |
dc.date.accessioned | 2022-05-25T15:21:00Z | - |
dc.date.available | 2018-01-23 | - |
dc.date.available | 2022-05-25T15:21:00Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | Cordero Sánchez, D.; Moreno Hernández, E. A. (2017). Incidencia, manejo y evolución de los pacientes con trombocitopenia primaria inmune tratados en la E.S.E. Hospital Universitario Erasmo Meoz durante el periodo 2014– 2016 [Trabajo de Grado Pregrado, Universidad de Pamplona]. Repositorio Hulago Universidad de Pamplona. http://repositoriodspace.unipamplona.edu.co/jspui/handle/20.500.12744/1095 | es_CO |
dc.identifier.uri | http://repositoriodspace.unipamplona.edu.co/jspui/handle/20.500.12744/1095 | - |
dc.description | Los autores no proporciona la información sobre este ítem. | es_CO |
dc.description.abstract | Los autores no proporciona la información sobre este ítem. | es_CO |
dc.format.extent | 46 | es_CO |
dc.format.mimetype | application/pdf | es_CO |
dc.language.iso | es | es_CO |
dc.publisher | Universidad de Pamplona – Facultad de Salud. | es_CO |
dc.subject | Tratamiento de erradicación. | es_CO |
dc.subject | Helicobacter Pylori. | es_CO |
dc.subject | Recuento de plaquetas. | es_CO |
dc.subject | Púrpura. | es_CO |
dc.subject | Trombocitopénica Idiopática. | es_CO |
dc.subject | Peliosis Hepática. | es_CO |
dc.subject | Hepatomegalia. | es_CO |
dc.subject | Esteroides. | es_CO |
dc.subject | Francia | es_CO |
dc.subject | Trombocitopenia Primaria Inmune. | es_CO |
dc.subject | Epidemiologia. | es_CO |
dc.subject | Incidencia. | es_CO |
dc.subject | Ivig. | es_CO |
dc.subject | Niños. | es_CO |
dc.subject | Tpi. | es_CO |
dc.subject | Salud relacionada con la calidad de vida. | es_CO |
dc.subject | Incidencia (2009). | es_CO |
dc.title | Incidencia, manejo y evolución de los pacientes con trombocitopenia primaria inmune tratados en la E.S.E. Hospital Universitario Erasmo Meoz durante el periodo 2014 – 2016. | es_CO |
dc.type | http://purl.org/coar/resource_type/c_7a1f | es_CO |
dc.date.accepted | 2017-10-23 | - |
dc.relation.references | 1. https://es.scribd.com/document/354667417/7) | es_CO |
dc.relation.references | 2. Michel, M. (2009), Immune thrombocytopenic purpura: epidemiology and implications for patients. European Journal of Haematology, 82: 3–7. doi: 10.1111/j.16000609.2008.01206.x | es_CO |
dc.relation.references | 3. http://www.medigraphic.com/pdfs/imss/im-2014/im143q.pdf | es_CO |
dc.relation.references | 4. https://demedicina.com/corticoides-efectos-secundarios/ | es_CO |
dc.relation.references | 5. http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=ES&Expert=3002 | es_CO |
dc.relation.references | 6. Leo C.A., Pravisani R., Bidinost S., Baccarani U., Bresadola V., Risaliti A., Terrosu G. Postsplenectomy recurrence of idiopathic thrombocitopenic purpura: role of laparoscopic splenectomy in the treatment of accessory spleen G Chir Vol. 36 - n. 4 - pp. 153-157 JulyAugust 2015 | es_CO |
dc.relation.references | 7. Kim, S. B., Kim, D. K., Byun, S. J., Park, J. H., Choi, J. Y., Park, Y. N., & Kim, D. Y. (2015). Peliosis hepatis presenting with massive hepatomegaly in a patient with idiopathic thrombocytopenic purpura. Clinical and Molecular Hepatology, 21(4), 387–392. http://doi.org/10.3350/cmh.2015.21.4.387 | es_CO |
dc.relation.references | 8. Hwang, J. J., Lee, D. H., Yoon, H., Shin, C. M., Park, Y. S., & Kim, N. (2016). The Effects of Helicobacter pylori Eradication Therapy for Chronic Idiopathic Thrombocytopenic Purpura. Gut and Liver, 10(3), 356–361. http://doi.org/10.5009/gnl14483 | es_CO |
dc.relation.references | 9. Hsiao, C.-H., Tseng, K.-C., Tseng, C.-W., & Tung, C.-H. (2015). Late-Onset Immune Thrombocytopenic Purpura After Withdrawal of Interferon Treatment for Chronic Hepatitis C Infection: A Case Report. Medicine, 94(34), e1296. http://doi.org/10.1097/MD.0000000000001296 | es_CO |
dc.relation.references | 10. W.-J. Dai, R.-R. Zhang, X.-C. Yang, Y.-F. Yuan Efficacy of standard dose rituximab for refractory idiopathic thrombocytopenic purpura in children. Eur Rev Med Pharmacol Sci 2015; 19 (13): 2379-2383 | es_CO |
dc.relation.references | 11. Moulis G, Palmaro A, Montastruc J, Godeau B, Lapeyre-Mestre M and Sailler L. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood Journal 2014, Novemeber 20 | es_CO |
dc.relation.references | 12. Emilia Parodi, Paola Giordano, Elisa Rivetti, Maria Teresa Giraudo, Giulia Ansaldi, Mirella Davitto, Anna Mondino, Piero Farruggia, Giovanni Amendola, Sofia M.R. Matarese, Francesca Rossi, Giovanna Russo, Ugo Ramenghi. Efficacy of combined intravenous immunoglobulins and steroids in children with primary immune thrombocytopenia and persistent bleeding symptoms. Blood Transfus 2014; 12: 340-5 | es_CO |
dc.relation.references | 13. http://www.medigraphic.com/pdfs/hematologia/re-2016/re164f.pdf | es_CO |
dc.relation.references | 14. Harrington WJ, Minnich V, Hollingsworth JW, Moore CV. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med. 1951 Jul;38(1):1-10. | es_CO |
dc.relation.references | 15. Shulman NR, Marder VJ, Weinrach RS. Similarities between know antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies. Ann N Y Acad Sci. 1965 Jun 30;124(2):499542 | es_CO |
dc.relation.references | 16. van Leeuwen EF, van der Ven JT, Engelfriet CP, von dem Borne AE. Specificity of autoantiboides in autoimmune thrombocytopenia. Blood. 192 Jan;59(1):23-6 | es_CO |
dc.relation.references | 17. Sukati H, Watson HG, Urbaniak SJ, Barket RN. Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune thrombocytopenic purpura. Blood. 2007 May 15; 109(10):4528-38 | es_CO |
dc.relation.references | 18. McMillan R, Wang L, Tani P. Prospective evaluation of the immunobed assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP). J Thromb Hemost. 2003 Mar;1(3):485-91 | es_CO |
dc.relation.references | 19. Brighton Ta, Evans S, Castaldi PA, Chesterman CN, Chong BH. Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood. 1996 Jul 1;88(1):194-201 | es_CO |
dc.relation.references | 20. Stockerlberg D, Hou M, Jacobsson S, Kutti J, Wadenvik H. Detection of platelet antibodies in chronic idiopathic thrombocytopenic purpura (ITP). A comparative study using flow cytometry, a whole platelet ELISA, and an antigen captura ELISA. Eur J Haematol. 1996 Jan-Feb;56(1-2):72-7. | es_CO |
dc.relation.references | 21. Kuwana M, Kaburaki J, Kitasato H, Kato M, Kawai S, Kwakami Y, et al. Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cell in patients with immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J Clin Invest. 1998 Oct 1;102(7):1393-402 | es_CO |
dc.relation.references | 22. Kuwana M, Kaburaki J, Kitasato H, Kato M, Kawai S, Kawakami Y, et al. Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cell in patients with immune thrombocytopenic purpura. Blood. 2001 Jul 1;98(1):130-9. | es_CO |
dc.relation.references | 23. Primer capítulo del libro (anexo fotos) | es_CO |
dc.relation.references | 24. http://www.medigraphic.com/pdfs/residente/rr-2015/rr153f.pdf | es_CO |
dc.relation.references | 25. Segundo capítulo del libro (anexo fotos) | es_CO |
dc.relation.references | 26. Stasi R; Willis F, Shannon Ms, Gordon-Smith EC. Infectious causes of chronic immune thrombocytopenia. Hematol Oncol Clin North Am. 2009 Dec;23(6):1275-97. | es_CO |
dc.relation.references | 27. Nardi MA, Liu LX, Karpatkin S. GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for antiplatelet GPIIIa of HIV-1 related immunologic thrombocytopenia. Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7589-94 | es_CO |
dc.relation.references | 28. Li Z, Nardi MA, Karpatkin S. Role of molecular mimicry to HIV-1 peptides in HIV-1 related immunologic thrombocytopenia. Blood. 2005 Jul 15;106(2):572-6. | es_CO |
dc.relation.references | 29. Zhang W, Nardi MA, BOrkowsky W, Li Z, Karpatkin S. Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatisis C-related immunologic thrombocytopenia. Blood. 2009 Apr 23;113(17):4086-93 | es_CO |
dc.relation.references | 30. Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pyloriassociated chronic idiopathic thrombocytopenic purpura. Br J Haematol. 2004 Jan;124(1):142-9. | es_CO |
dc.relation.references | 31. Stasi R, Sarpatwari A, Segal JB, Osborn J, Evangelista ML, Cooper N, et al. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood. 2009 Feb 5;113(6):1231-40. | es_CO |
dc.relation.references | 32. http://www.medigraphic.com/pdfs/hematologia/re-2016/re164f.pdf | es_CO |
dc.relation.references | 33. tercer capitulo del libro: The diagnosis and management of chronic immune thrombocytopenia in adults (anexo fotos) | es_CO |
dc.relation.references | 34. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: Pathogenic and clinical diversity. Blood. 2009;113:6511-21. | es_CO |
dc.relation.references | 35. Cines DB, Liebman H; Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol. 2009;46:S2-14. | es_CO |
dc.relation.references | 36. Cines DB. Pathogensis of ITP. In Cines DB, Kuter DJ, Newland AC, Povan D, Semple, JW, editors, Immune Thrombocytopenia: The Handbook. 2011ESH Forum Service Editore. P. 77-89 | es_CO |
dc.relation.references | 37. http://www.medigraphic.com/pdfs/residente/rr-2015/rr153f.pdf | es_CO |
dc.relation.references | 38. Provan D, Newland AC, et al. British Committee for Standars in Haematology, General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003;120:574-96. | es_CO |
dc.relation.references | 39. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3-40 | es_CO |
dc.relation.references | 40. Mazzucconi NG, Fazi P, Bernasconi S, et al. Therapy with high-dose dexamethasone (HDDXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura. A GIMEMA experience. Blood. 2007;109:1401-7. | es_CO |
dc.relation.references | 41. Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood. 2001;97:2549-54. | es_CO |
dc.relation.references | 42. Stasi R, Stipa E, Masi M, et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med. 1995;98:436-42. | es_CO |
dc.relation.references | 43. http://www.bloodjournal.org/content/117/16/4190?sso-checked=true | es_CO |
dc.relation.references | 44. Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: A systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004;104:2623-34. | es_CO |
dc.relation.references | 45. Wanachiwanawin W, Visudhiphan S, pinankijagum A, Vatanavicharn S. Therapy of chronic idiopathic thrombocytopenic purpura in adult: Experiences from Thailand. Southeast Asian J Trop Med Public Health. 1993;24(Suppl 1):71-5. | es_CO |
dc.relation.references | 46. Robinette CD, Fraumeni JF. Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet .1977;ii:127-9. | es_CO |
dc.relation.references | 47. Bisharat N, Omari H, Lavi I, Raz R. Risk of infection and death among post-splenectomy patients. J Infect. 2001;43:182-6. | es_CO |
dc.relation.references | 48. Schwartz J, Leber MD, Gilis S, et al. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol. 2003;72:94-8. | es_CO |
dc.relation.references | 49. McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppresion of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood. 2004;103:1364-1369. | es_CO |
dc.relation.references | 50. Olsson B, Andersson PO, Jernas M, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003;9:1123-4. | es_CO |
dc.relation.references | 51. Yu J, Heck S, Patel V, et al. Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura. Blood. 2008;112:1325-8. | es_CO |
dc.relation.references | 52. https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000200008 | es_CO |
dc.relation.references | 53. http://www.medigraphic.com/pdfs/hematologia/re-2010/re102g.pdf | es_CO |
dc.relation.references | 54. https://www.pediatriaintegral.es/numeros-anteriores/publicacion-2012-06/interpretaciondel-hemograma/ | es_CO |
dc.relation.references | 55. http://www.who.int/vmnis/indicators/haemoglobin_es.pdf | es_CO |
dc.rights.accessrights | http://purl.org/coar/access_right/c_abf2 | es_CO |
dc.type.coarversion | http://purl.org/coar/resource_type/c_2df8fbb1 | es_CO |
Aparece en las colecciones: | Medicina |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Cordero_Moreno_2017_TG.pdf | Cordero_Moreno_2017_TG | 785,56 kB | Adobe PDF | Visualizar/Abrir |
Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.